Bank of New Hampshire Reduces Stock Holdings in Colgate-Palmolive (NYSE:CL)

Bank of New Hampshire lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 7.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 7,748 shares of the company’s stock after selling 628 shares during the period. Bank of New Hampshire’s holdings in Colgate-Palmolive were worth $704,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the third quarter valued at $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive in the 3rd quarter worth about $53,000. Prospera Private Wealth LLC bought a new stake in Colgate-Palmolive in the third quarter worth about $64,000. True Wealth Design LLC boosted its position in shares of Colgate-Palmolive by 1,460.9% during the third quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after buying an additional 672 shares during the period. Finally, Continuum Advisory LLC grew its stake in shares of Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after buying an additional 368 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Colgate-Palmolive Stock Up 0.6 %

NYSE:CL traded up $0.54 during mid-day trading on Tuesday, hitting $88.08. 292,166 shares of the company’s stock traded hands, compared to its average volume of 3,156,969. The company has a market capitalization of $71.96 billion, a P/E ratio of 25.24, a P/E/G ratio of 3.31 and a beta of 0.44. The company has a fifty day moving average of $93.18 and a 200 day moving average of $98.38. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a twelve month low of $79.69 and a twelve month high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.27%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analysts Set New Price Targets

A number of brokerages recently issued reports on CL. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their target price for the company from $105.00 to $101.00 in a research note on Monday, October 28th. TD Cowen reduced their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and upped their target price for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $104.63.

Insider Buying and Selling

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.